Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

COPD linked to mild cognitive impairment risk

Research shows that elderly patients with chronic obstructive pulmonary disease are nearly twice as likely as those without to have mild cognitive impairment.

8 Nov 2013

Patrys gets second US patent for anti-cancer product PAT-LM1

Patrys Limited, a clinical stage biotechnology company is pleased to advise that it has been granted a second US patent for lead anti-cancer product PAT-LM1.

8 Nov 2013

New zebrafish technique finds potential treatments for multiple diseases

Skeletal muscle has proved to be very difficult to grow in patients with muscular dystrophy and other disorders that degrade and weaken muscle. Researchers at Boston Children's Hospital's Stem Cell Program now report boosting muscle mass and reversing disease in a mouse model of Duchenne muscular dystrophy, using a "cocktail" of three compounds identified through a new rapid culture system. Adding the same compounds to stem cells derived from patients' skin cells, they then successfully grew human muscle cells in a dish.

8 Nov 2013

Northwestern Medicine receives $12 million to continue organ transplant research with stem cells

An innovative Northwestern Medicine- research program investigating if stem cells may be the key to allowing organ transplant patients to stop taking immunosuppressive drugs has received $12 million in research funding. The grant will allow researchers to finish Phase II of the clinical trials and begin Phase III.

8 Nov 2013

Children's Hospital Los Angeles opens new outpatient care center in Santa Monica

Children's Hospital Los Angeles opened the doors of its new outpatient care center in Santa Monica today. The pediatric medical facility, Children's Hospital Los Angeles - Santa Monica, will be staffed by 10 physicians who are Board-Certified in seven specialties and subspecialties, including hematology-oncology, medical genetics, neurology, orthopaedics, plastic and maxillofacial surgery, and urology.

8 Nov 2013

Investigators find potential new target for treatment of low-grade gliomas

Investigators at Johns Hopkins have found a known genetic pathway to be active in many difficult-to-treat pediatric brain tumors called low-grade gliomas, potentially offering a new target for the treatment of these cancers.

7 Nov 2013

New 4th generation HIV assays now available to improve screening for HIV infection

Laboratory Corporation of America Holdings announced today the availability of a 4th generation HIV antigen/antibody combination assay and a new diagnostic algorithm that improves screening for HIV infection.

6 Nov 2013

Alliance HealthCare Services third quarter 2013 revenue decreases $2.6 million

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, announced results for the third quarter ended September 30, 2013.

6 Nov 2013

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

The prostate gland produces part of the seminal fluid that protects sperm. It is located in front of the rectum and under the bladder, and surrounds the urethra, the tube through which urine flows from the bladder to and out of the penis.

6 Nov 2013

New drug combination therapy effectively kills cancer cells

Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.

6 Nov 2013

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

ADC Therapeutics Sarl, a portfolio company of Auven Therapeutics and the oncology drug development company specializing in proprietary antibody drug conjugates, and Five Prime Therapeutics, Inc., a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced an exclusive license agreement for human antibodies directed to an undisclosed target expressed on the surface of various types of cancers.

6 Nov 2013

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

The go-to source for excellence in continuing medical education, Physicians' Education Resource®, LLC, will host the 11th Annual School of Breast Oncology November 7-10 at the Emory University Conference Center in Atlanta, GA.

6 Nov 2013

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.

6 Nov 2013

Jazz Pharmaceuticals announces third quarter financial results and updated 2013 guidance

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the third quarter ended September 30, 2013 and updated 2013 financial guidance.

6 Nov 2013

Ventana partners with Incyte to develop companion diagnostic tests for oncology drug programs

Ventana Medical Systems, Inc., a member of the Roche Group, today announced that it has entered into an agreement with Incyte Corporation to collaborate on the development of companion diagnostic tests for Incyte's oncology drug programs, beginning with the Incyte IDO1 inhibitor program.

5 Nov 2013

Aeterna Zentaris submits macimorelin acetate NDA to FDA

Aeterna Zentaris Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration ("FDA") for its ghrelin agonist, macimorelin acetate (AEZS-130).

5 Nov 2013

Stanford researchers receive $1.37M grant to study on immune systems of pediatric cancer patients

Kathleen Sakamoto, MD, PhD, and Irving Weissman, MD, of the Stanford University School of Medicine and Lucile Packard Children's Hospital, have received a $1.37 million grant from CureSearch for Children's Cancer to research the effects of an antibody that has been shown to be effective against human cancers in animal models.

5 Nov 2013

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Zevacor Molecular, an independently owned healthcare firm that manufactures and distributes PET and SPECT radiopharmaceuticals, has purchased the first 70 MeV Cyclotron dedicated to medical use in the United States from Ion Beam Applications, S.A.

5 Nov 2013

Biothera announces top-line results from Phase 2b clinical trial in non-small cell lung cancer

Biothera announced today top-line results from its Phase 2b clinical trial in non-small cell lung cancer (NSCLC) that evaluated its immunotherapeutic drug candidate, Imprime PGG®, with cetuximab (Erbitux®), carboplatin and paclitaxel compared with the monoclonal antibody and chemotherapy combination alone.

5 Nov 2013

The Princess Margaret Cancer Foundation launches innovative Fall advertising campaign

The Princess Margaret Cancer Foundation launches an innovative Fall advertising campaign this month which focuses on the extraordinary team of 63 surgeons, all of whom who are integral reasons why the Princess Margaret Cancer Centre is one of the top 5 cancer research centres in the world.

5 Nov 2013

Oncology News and Research

Further Reading

COPD linked to mild cognitive impairment risk

Patrys gets second US patent for anti-cancer product PAT-LM1

New zebrafish technique finds potential treatments for multiple diseases

Northwestern Medicine receives $12 million to continue organ transplant research with stem cells

Children's Hospital Los Angeles opens new outpatient care center in Santa Monica

Investigators find potential new target for treatment of low-grade gliomas

New 4th generation HIV assays now available to improve screening for HIV infection

Alliance HealthCare Services third quarter 2013 revenue decreases $2.6 million

Advanced prostate cancer therapies: an interview with Dr. Nancy Dawson, Lombardi Comprehensive Cancer Center

New drug combination therapy effectively kills cancer cells

ADC Therapeutics, Five Prime sign exclusive license agreement for human antibodies

Physicians' Education Resource to host 11th Annual School of Breast Oncology in Atlanta, GA

FDA grants Orphan Drug Designation to Advaxis' ADXS-HPV for HPV-associated head and neck cancer

Jazz Pharmaceuticals announces third quarter financial results and updated 2013 guidance

Ventana partners with Incyte to develop companion diagnostic tests for oncology drug programs

Aeterna Zentaris submits macimorelin acetate NDA to FDA

Stanford researchers receive $1.37M grant to study on immune systems of pediatric cancer patients

Zevacor Molecular buys 70 MeV Cyclotron dedicated to medical use from IBA

Biothera announces top-line results from Phase 2b clinical trial in non-small cell lung cancer

The Princess Margaret Cancer Foundation launches innovative Fall advertising campaign

eBook: Liquid biopsy in cancer research eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News